BioNeutra Global Verschuldung / Eigenkapital

Was ist das Verschuldung / Eigenkapital von BioNeutra Global?

Verschuldung / Eigenkapital von BioNeutra Global Corporation ist -6.26

Was ist die Definition von Verschuldung / Eigenkapital?

Die Verschuldung zu Eigenkapital ist ein Finanzverhältnis, das den relativen Anteil des Eigenkapitals und der Verschuldung angibt, die zur Finanzierung der Vermögenswerte eines Unternehmens verwendet werden.

The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.

Was macht BioNeutra Global?

BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides. The company's lead product is VitaFiber, an isomalto-oligosaccharide functional and health food ingredient that offers low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers in in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. BioNeutra Global Corporation is based in Edmonton, Canada.

Unternehmen mit verschuldung / eigenkapital ähnlich BioNeutra Global